These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19342624)

  • 21. B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients.
    Shubin NJ; Monaghan SF; Heffernan DS; Chung CS; Ayala A
    Crit Care; 2013 Nov; 17(6):R276. PubMed ID: 24289156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.
    Huarte E; Jun S; Rynda-Apple A; Golden S; Jackiw L; Hoffman C; Maddaloni M; Pascual DW
    J Immunol; 2016 Jun; 196(12):5036-46. PubMed ID: 27194787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B and T lymphocyte attenuator tempers early infection immunity.
    Sun Y; Brown NK; Ruddy MJ; Miller ML; Lee Y; Wang Y; Murphy KM; Pfeffer K; Chen L; Kaye J; Fu YX
    J Immunol; 2009 Aug; 183(3):1946-51. PubMed ID: 19587015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs.
    Chemnitz JM; Lanfranco AR; Braunstein I; Riley JL
    J Immunol; 2006 Jun; 176(11):6603-14. PubMed ID: 16709818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.
    Wang Z; Yang H; Liu X; Zhang J; Han Z; Tao J; Zhao C; Ju X; Tan R; Gu M
    Med Sci Monit; 2018 Jan; 24():387-396. PubMed ID: 29352109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts.
    Tao R; Wang L; Han R; Wang T; Ye Q; Honjo T; Murphy TL; Murphy KM; Hancock WW
    J Immunol; 2005 Nov; 175(9):5774-82. PubMed ID: 16237069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting Edge: the BTLA-HVEM regulatory pathway interferes with protective immunity to intestinal Helminth infection.
    Breloer M; Hartmann W; Blankenhaus B; Eschbach ML; Pfeffer K; Jacobs T
    J Immunol; 2015 Feb; 194(4):1413-6. PubMed ID: 25595777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1.
    Watanabe N; Gavrieli M; Sedy JR; Yang J; Fallarino F; Loftin SK; Hurchla MA; Zimmerman N; Sim J; Zang X; Murphy TL; Russell JH; Allison JP; Murphy KM
    Nat Immunol; 2003 Jul; 4(7):670-9. PubMed ID: 12796776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and clinical significance of B and T lymphocyte attenuator on CD4
    Shen X; Zhang J; Tang P; Song H; Liu X; Huang Z; Zhang X; Wang X; Wu M
    Indian J Pathol Microbiol; 2019; 62(2):232-238. PubMed ID: 30971546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells.
    Otsuki N; Kamimura Y; Hashiguchi M; Azuma M
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1121-7. PubMed ID: 16643847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifaceted Role of BTLA in the Control of CD8
    Ritthipichai K; Haymaker CL; Martinez M; Aschenbrenner A; Yi X; Zhang M; Kale C; Vence LM; Roszik J; Hailemichael Y; Overwijk WW; Varadarajan N; Nurieva R; Radvanyi LG; Hwu P; Bernatchez C
    Clin Cancer Res; 2017 Oct; 23(20):6151-6164. PubMed ID: 28754817
    [No Abstract]   [Full Text] [Related]  

  • 32. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.
    Cheung TC; Oborne LM; Steinberg MW; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
    J Immunol; 2009 Dec; 183(11):7286-96. PubMed ID: 19915044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.
    Karabon L; Partyka A; Ciszak L; Pawlak-Adamska E; Tomkiewicz A; Bojarska-Junak A; Roliński J; Wołowiec D; Wrobel T; Frydecka I; Kosmaczewska A
    J Immunol Res; 2020; 2020():6545921. PubMed ID: 32775467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic expansion of virus-specific CD8
    Wang H; Wu B; Li L; Hu L; Lin J; Jiang C; Cai G; Shen Q
    Cell Immunol; 2017 Jan; 311():36-45. PubMed ID: 27743606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of B and T lymphocyte attenuator, retinoid-related orphan receptor gamma-isoform-t and interleukin 7 in psoriasis vulgaris.
    Youssef RM; El-Ramly AZ; Hussien MF; Shoukry NM; Amr K
    Australas J Dermatol; 2019 May; 60(2):e132-e137. PubMed ID: 30671936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
    Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutting edge: B and T lymphocyte attenuator signaling on NKT cells inhibits cytokine release and tissue injury in early immune responses.
    Miller ML; Sun Y; Fu YX
    J Immunol; 2009 Jul; 183(1):32-6. PubMed ID: 19535622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection.
    Yu X; Zheng Y; Mao R; Su Z; Zhang J
    Front Immunol; 2019; 10():617. PubMed ID: 30984188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. THEMIS promotes T cell development and maintenance by rising the signaling threshold of the inhibitory receptor BTLA.
    Mélique S; Vadel A; Rouquié N; Yang C; Bories C; Cotineau C; Saoudi A; Fazilleau N; Lesourne R
    Proc Natl Acad Sci U S A; 2024 May; 121(20):e2318773121. PubMed ID: 38713628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells.
    Werner K; Dolff S; Dai Y; Ma X; Brinkhoff A; Korth J; Gäckler A; Rohn H; Sun M; Cohen Tervaert JW; van Paassen P; Kribben A; Witzke O; Wilde B
    Front Immunol; 2019; 10():2843. PubMed ID: 31921121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.